SCHEMBL9728833

SCHEMBL9728833

c1cnc2cc3scnc3cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.49
CASP6 P55212 1/20 0.47
NPC1 O15118 4/20 0.46
RAB9A P51151 2/20 0.46
POLB P06746 1/20 0.46
PDGFRB P09619 1/20 0.44
PDGFRA P16234 1/20 0.44
ALDH1A1 P00352 6/20 0.44
HSD17B10 Q99714 2/20 0.44
CASP1 P29466 2/20 0.43
HTT P42858 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
CASP7 P55210 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
NR4A2 P43354 1/20 0.43
TP53 P04637 1/20 0.43
HSP90AA1 P07900 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1156175 0.80 ALDH1A1 (0.56) RIPK1NPC1RAB9AALDH1A1HSD17B10
SCHEMBL150476 0.79 NPC1 (0.65) CASP6NPC1RAB9APOLBPDGFRB
SCHEMBL29350099 0.79 NPC1 (0.65) CASP6NPC1RAB9APOLBPDGFRB
SCHEMBL4137599 0.77 ALDH1A1 (0.52) RIPK1NPC1RAB9AALDH1A1HSD17B10
SCHEMBL4296143 0.77 ALDH1A1 (0.52) RIPK1NPC1RAB9AALDH1A1HSD17B10
SCHEMBL13156510 0.75 NPC1 (0.60) CASP6NPC1RAB9APOLBPDGFRB
SCHEMBL13156520 0.75 NPC1 (0.60) CASP6NPC1RAB9APOLBPDGFRB
SCHEMBL18700662 0.75 NPC1 (0.60) CASP6NPC1RAB9APOLBPDGFRB
SCHEMBL12532559 0.75 NPC1 (0.60) CASP6NPC1RAB9APOLBPDGFRB
Quinoline SCHEMBL23391635 0.74 ALDH1A1 (0.70) RIPK1CASP6NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0254179-A2 Tetrahydrobenzothiazoloquinolines, their preparation and use BOEHRINGER INGELHEIM KG (DE) 1988-01-27 EP claimed
EP-0250179-A2 BCD tricyclic ergoline part-structure analogues ELI LILLY AND COMPANY (US) 1987-12-23 EP claimed
US-5134143-A Dopamine Agonists ELI LILLY AND COMPANY (US) 1992-07-28 US disclosed
US-5134143-A Dopamine Agonists ELI LILLY AND COMPANY (US) 1992-07-28 US disclosed
CN-1016872-B BCD TRICYCLIC ERGOLINE PART-STRUCTURE ANALOGUSE LILLY CO ELI (US) 1992-06-03 CN disclosed
US-4977160-A DOPAMINE AGONISTS; PARKINSON*S DISEASE ELI LILLY AND COMPANY (US) 1990-12-11 US disclosed
US-4977160-A DOPAMINE AGONISTS; PARKINSON*S DISEASE ELI LILLY AND COMPANY (US) 1990-12-11 US disclosed
US-4826986-A DOPAMINE AGONISTS ELI LILLY AND COMPANY (US) 1989-05-02 US disclosed
US-4826986-A DOPAMINE AGONISTS ELI LILLY AND COMPANY (US) 1989-05-02 US disclosed
EP-0250179-A2 BCD tricyclic ergoline part-structure analogues ELI LILLY AND COMPANY (US) 1987-12-23 EP disclosed
US-4537964-A Method of preparing permissibly-substituted 1H(and 2H)pyrazolo[3,4-g]quinolines; pyrimido[4,5,g]quinolines; thiazolo[4,5,g]quinolines and intermediates therefore ELI LILLY AND COMPANY (US) 1985-08-27 US disclosed